BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14981811)

  • 1. [In situ expression of transforming growth factor beta 1 in the process of induction chemotherapy for oral squamous cell carcinoma].
    Tang W; Tian WD; Li SW; Tang YC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):42-3, 90. PubMed ID: 14981811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The expression in situ of transforming growth factor beta s, their receptors and TGF beta-receptor interacting protein-1 in nasopharygneal carcinoma].
    Bin L; Hu C; Zhan F
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Aug; 34(4):210-2. PubMed ID: 12764773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of transforming growth factor beta(TGF-beta) subtypes in oral squamous cell carcinoma].
    Jin X; Li J; Li Z; Li Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Dec; 19(6):377-9. PubMed ID: 12539688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
    Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R
    Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of transforming growth factor-beta1 on EDA region of fibronectin in oral squamous cell carcinoma and adenoid cystic carcinoma cells].
    Zhang JP; Li CY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Jan; 42(1):47-51. PubMed ID: 17331445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx.
    Kojc N; Zidar N; Vodopivec B; Gale N
    Hum Pathol; 2005 Jan; 36(1):16-21. PubMed ID: 15712177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of local immunotherapy of interleukin 2(IL-2) in combination with chemotherapy upon intratumoral lymphocytes in oral squamous cell carcinomas].
    Tang E; Hu Q; Zhou B
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Dec; 21(6):444-6. PubMed ID: 14732977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide.
    Hrycek A; Kusmierz D; Dybała T; Swiatkowska L
    Autoimmunity; 2007 Feb; 40(1):23-30. PubMed ID: 17364494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of transforming growth factor-beta1 in cervical squamous carcinoma cell and stroma].
    Li XG; Zou XH; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):44-6. PubMed ID: 16137003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
    Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
    Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
    J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation.
    Kellermann MG; Sobral LM; da Silva SD; Zecchin KG; Graner E; Lopes MA; Kowalski LP; Coletta RD
    Oral Oncol; 2008 May; 44(5):509-17. PubMed ID: 17826300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta isoforms (TGF-beta1, TGF-beta2, TGF-beta3) messenger RNA expression in laryngeal cancer.
    Kapral M; Strzalka B; Kowalczyk M; Jurzak M; Mazurek U; Gierek T; Paluch J; Markowski J; Swiatkowska L; Weglarz L
    Am J Otolaryngol; 2008; 29(4):233-7. PubMed ID: 18598833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma.
    Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM
    Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy with higher or lower dose of teniposide combined with cisplatin and pingyangmycin for oral squamous cell carcinoma].
    Chen WT; Guo W; Xu Q; Pan HY; Ye DX; Qiu WL
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 May; 39(3):218-20. PubMed ID: 15196390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of TGF-beta1 suppresses motility and invasiveness of oral squamous cell carcinoma cell lines via modulation of integrins and down-regulation of matrix-metalloproteinases.
    Takayama S; Hatori M; Kurihara Y; Kinugasa Y; Shirota T; Shintani S
    Oncol Rep; 2009 Jan; 21(1):205-10. PubMed ID: 19082463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of TGF-beta1 expression of lung cancer in Gejiu miners with that in non-miners in other regions].
    Jiang P; Jin KW; Gao Q
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Feb; 22(1):36-8. PubMed ID: 15033015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.